The brain on MDMA can go somewhere CBT has never been able to reach | Rachel Yehuda: Full Interview

This interview with Rachel Yehuda provides a compelling and accessible overview of PTSD, trauma mechanisms, and the promise of MDMA-assisted therapy. Yehuda’s credentials as a leading PTSD researcher lend authority to the discussion. She clearly distinguishes stress from trauma, explaining that trauma involves a lasting transformation of self-perception and biology, which is a key insight for understanding why conventional therapies often fail. The explanation of how trauma warps self-perception (e.g., self-blame, guilt) is well-articulated and grounded in clinical experience. The core argument that MDMA allows patients to access emotional states that CBT cannot reach is supported by phase 2/3 trial data showing two-thirds of participants no longer meet PTSD criteria. However, the interview lacks specific citations for these trials, and the description of MDMA’s mechanism (calm, coherent state) is simplified. The section on epigenetics is intriguing but controversial; while Yehuda’s own research on Holocaust survivors is cited, the claim that healing can be passed intergenerationally is speculative and not yet supported by strong evidence. The interview does not address potential risks of MDMA therapy (e.g., cardiovascular effects, misuse) or the regulatory hurdles it faces. The societal narrative critique is insightful but could be seen as blaming the victim. Overall, the information is high-quality and well-presented, but the lack of detailed references and the speculative nature of some claims prevent a perfect score. The title accurately captures the central thesis. The interview is a valuable contribution to public understanding of trauma and innovative therapies.

The title accurately reflects the core argument: MDMA-assisted therapy can access emotional states that CBT cannot, as explained by Yehuda.

Rachel Yehuda is a leading PTSD researcher with decades of experience. The interview presents well-established concepts (epigenetics, PTSD mechanisms) and references ongoing clinical trials for MDMA-assisted therapy. However, some claims (e.g., intergenerational transmission of trauma) are still debated, and the format lacks detailed citations for specific studies.

• 00:00Introduction: What trauma does to the brain
• 00:20Chapter 1: Why trauma sticks
• 03:05Stress vs. trauma: what's the difference?
• 05:55Why most people don't develop PTSD
• 08:37Chapter 2: How MDMA-assisted therapy can break the loop
• 09:19How trauma warps self-perception
• 12:40MDMA-assisted therapy explained
• 16:38How societal narratives shape recovery (or worsen it)
• 23:04The reality of psychedelic therapy (not a quick fix)
• 28:55Chapter 3: Healing can echo across generations
• 30:48Epigenetics explained
• 40:00Can healing be passed on too?
• 43:43PTSD beyond fear: guilt, shame, and trauma
• 47:01What real healing looks like

• Big Think Membership — Promotional link for Big Think membership.
• Full interview with David Linden — Suggested next video on bizarre phenomena in medicine.
• Video transcript on Big Think — Transcript of this interview.

• MDMA-assisted psychotherapy for PTSD: a systematic review and meta-analysis — Supports the efficacy of MDMA therapy for PTSD.
• Epigenetic transmission of trauma in Holocaust survivors — Yehuda's own study showing epigenetic changes in offspring.

• Concerns about MDMA therapy safety and efficacy — Some researchers question the long-term safety and methodological rigor of MDMA trials, citing potential cardiovascular risks and lack of long-term follow-up.